SELPLG

P-selectin glycoprotein ligand 1 · Q14242 · SELPLG on Sugi Atlas →

666 patent compounds predicted against SELPLG, 528 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Bimosiamose (SCHEMBL2529148)	1.00	1/20
SCHEMBL7614341	1.00	1/20
SCHEMBL7620761	1.00	1/20
Bimosiamose (SCHEMBL12182030)	1.00	1/20
Bimosiamose (SCHEMBL14015902)	1.00	1/20
Bimosiamose (SCHEMBL14970212)	1.00	1/20
Bimosiamose (SCHEMBL26341832)	1.00	1/20
Bimosiamose (SCHEMBL29367817)	1.00	1/20
Bimosiamose (SCHEMBL29372538)	1.00	1/20
Bimosiamose (SCHEMBL2528669)	0.98	1/20
SCHEMBL7619803	0.98	1/20
SCHEMBL8205205	0.98	1/20
SCHEMBL8200837	0.91	1/20
SCHEMBL13390070	0.91	1/20
SCHEMBL12216369	0.90	1/20
SCHEMBL13056320	0.88	1/20
Bimosiamose (SCHEMBL29438584)	0.84	1/20
SCHEMBL4666940	0.84	1/20
SCHEMBL7611361	0.81	1/20
SCHEMBL13390119	0.81	1/20

Clinical trials — most relevant to SELPLG by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
COMT on Aspirin Platelets Effects (CAPE)	PHASE4	UNKNOWN
Crizanlizumab for Treating COVID-19 Vasculopathy	PHASE2	COMPLETED
The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy	PHASE2	SUSPENDED
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis	PHASE2	WITHDRAWN
E-Selectin Nasal Instillation to Prevent Secondary Stroke	PHASE1	WITHDRAWN
Investigation of the Influence of Gender on Cardiovascular Function	EARLY_PHASE1	COMPLETED
Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling	nan	WITHDRAWN
Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients	nan	COMPLETED
Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus	nan	COMPLETED
Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial	nan	COMPLETED
Endothelial Dysfunction and Selenium Status in Children With Acute Systemic Inflammatory Response	nan	COMPLETED
The Effect of Vitamin D Supplementation on HIV-associated Platelet Hyperreactivity	nan	COMPLETED
Impact of Combination of Clopidogrel With Aspirin on Postoperative Bleeding in Coronary Surgical Patients	nan	COMPLETED
Assessment of Platelet Storage Lesion(PSL)in Platelet Concentrates	nan	UNKNOWN
ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer	nan	UNKNOWN
Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment	nan	COMPLETED
Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease	nan	UNKNOWN
Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients	nan	UNKNOWN
Correlation Between PLA Levels and Disease Severity in Patients With Sepsis Cardiac Insufficiency	nan	RECRUITING
Noninvasive Evaluation of Cardiac Allograft Vasculopathy	nan	WITHDRAWN
Noninvasive Predictors of Transplant Vasculopathy	nan	WITHDRAWN
PROgnostic Value of MicroParticles and Markers of Hemostasis in TIA and Ischemic Stroke	nan	COMPLETED
The Relationship of Change of Dendritic Cells Fractalkine and P-selectin Patients With Acute Myocardial Infarction	nan	COMPLETED
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis	nan	UNKNOWN
Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction	nan	COMPLETED
The Effect of Pulsed-field and Radiofrequency Ablation on Platelet, Coagulation and Inflammation	nan	UNKNOWN
Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer	nan	COMPLETED
Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery	nan	COMPLETED
Circulating Endothelial Compartment During Normal and Pathological Aging	nan	COMPLETED
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a SELPLG binder may also engage these)

Protein	Name	Similarity
Q62170	—	0.990	Q62170 →
P16150	—	0.978	P16150 →
P15702	—	0.977	P15702 →
Q8N307	—	0.977	Q8N307 →
O35930	—	0.976	O35930 →
Q4V7A5	—	0.975	Q4V7A5 →
Q96F05	—	0.975	Q96F05 →
Q02496	—	0.974	Q02496 →
P13838	—	0.972	P13838 →
O15069	—	0.971	O15069 →
Q63560	—	0.971	Q63560 →
Q9ET66	—	0.971	Q9ET66 →
Q29435	—	0.971	Q29435 →
Q91WD8	—	0.970	Q91WD8 →
A0A0J9YY54	—	0.970	A0A0J9YY54 →
Q6P752	—	0.970	Q6P752 →
Q8JZQ0	—	0.970	Q8JZQ0 →
P17564	—	0.970	P17564 →
Q9PU53	—	0.970	Q9PU53 →
Q2EG98	—	0.969	Q2EG98 →
Q8N687	—	0.969	Q8N687 →
A5D7L8	—	0.969	A5D7L8 →
P24587	—	0.969	P24587 →
Q8CAE9	—	0.969	Q8CAE9 →
O46598	—	0.968	O46598 →
D3YVF0	—	0.968	D3YVF0 →
A6NMS7	—	0.968	A6NMS7 →
F1LWT0	—	0.968	F1LWT0 →
Q8N1P7	—	0.968	Q8N1P7 →
Q6ITT4	—	0.968	Q6ITT4 →